SAN DIEGO, July 2, 2020 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP is investigating potential violations of federal and state laws by certain officers of the companies listed below.
Company Name | Stock Ticker | If You Have Held | Join the Action |
Apyx Medical Corporation | APYX | 8/1/2018 | |
ViewRay, Inc. | VRAY | 5/10/2018 | |
Intersect ENT, Inc. | XENT | 8/1/2018 | |
Fifth Third Bancorp | FITB | 2/26/2016 | |
AnaptysBio, Inc. | ANAB | 10/10/2017 | |
Mohawk Industries, Inc. | MHK | 3/3/2020 | |
GlobalSCAPE, Inc. | GSB | 1/26/2017 | |
ServiceMaster Global Holdings, Inc. | SERV | 2/26/2019 | |
Grand Canyon Education, Inc. | LOPE | 1/5/2018 | |
Fluor Corporation | FLR | 11/2/2017 |
Securities fraud class-action lawsuits have been filed on behalf of shareholders for the above publicly-traded companies. If you are a long-term shareholder of any of these companies and have held shares continuously as dates listed, you may have standing to hold the officers and directors liable for company losses; assisting in holding the company harmless and potentially reforming corporate governance to prevent future wrongdoing.
If you are interested in learning more about the investigation, please contact Lead Analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If you email, please include your phone number.
If you have continuously owned any of the companies mentioned above since the specified date [click here to join this action]. There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com
SOURCE Johnson Fistel, LLP
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.